{"id":"https://openalex.org/W2074466053","doi":"https://doi.org/10.1016/j.ophtha.2015.01.025","title":"Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization","display_name":"Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization","publication_year":2015,"publication_date":"2015-03-04","ids":{"openalex":"https://openalex.org/W2074466053","doi":"https://doi.org/10.1016/j.ophtha.2015.01.025","mag":"2074466053","pmid":"https://pubmed.ncbi.nlm.nih.gov/25745875"},"language":"en","primary_location":{"id":"doi:10.1016/j.ophtha.2015.01.025","doi":"https://doi.org/10.1016/j.ophtha.2015.01.025","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ophtha.2015.01.025","pdf_url":null,"source":{"id":"https://openalex.org/S207341048","display_name":"Ophthalmology","issn_l":"0161-6420","issn":["0161-6420","1549-4713"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071301207","display_name":"Yasushi Ikuno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasushi Ikuno","raw_affiliation_strings":["Department of Ophthalmology, Osaka University School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Osaka University School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043555116","display_name":"Kyoko Ohno\u2010Matsui","orcid":"https://orcid.org/0000-0002-8375-6879","observed_orcids":["https://orcid.org/0000-0002-8375-6879"]},"institutions":[{"id":"https://openalex.org/I125602781","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31","country_code":"JP","type":"education","lineage":["https://openalex.org/I125602781","https://openalex.org/I4400009020"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kyoko Ohno-Matsui","raw_affiliation_strings":["Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan","institution_ids":["https://openalex.org/I125602781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072258594","display_name":"Tien Yin Wong","orcid":"https://orcid.org/0000-0002-8448-1264","observed_orcids":["https://orcid.org/0000-0002-8448-1264"]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]},{"id":"https://openalex.org/I2799299286","display_name":"Singapore National Eye Center","ror":"https://ror.org/029nvrb94","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2799299286"]},{"id":"https://openalex.org/I4210116917","display_name":"Singapore Eye Research Institute","ror":"https://ror.org/02crz6e12","country_code":"SG","type":"facility","lineage":["https://openalex.org/I4210116917"]},{"id":"https://openalex.org/I4210126319","display_name":"Duke-NUS Medical School","ror":"https://ror.org/02j1m6098","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I170897317","https://openalex.org/I4210126319"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Tien Yin Wong","raw_affiliation_strings":["Singapore Eye Research Institute, Singapore National Eye Center, Duke-NUS Graduate Medical School, National University of Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Singapore Eye Research Institute, Singapore National Eye Center, Duke-NUS Graduate Medical School, National University of Singapore, Singapore","institution_ids":["https://openalex.org/I165932596","https://openalex.org/I2799299286","https://openalex.org/I4210116917","https://openalex.org/I4210126319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077640743","display_name":"Jean\u2010Fran\u00e7ois Korobelnik","orcid":"https://orcid.org/0000-0002-4438-9535","observed_orcids":["https://orcid.org/0000-0002-4438-9535"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210112727","display_name":"H\u00f4pital Pellegrin","ror":"https://ror.org/02x581406","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]},{"id":"https://openalex.org/I4405256745","display_name":"Universit\u00e9 Bordeaux Segalen","ror":"https://ror.org/04gbzm373","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Francois Korobelnik","raw_affiliation_strings":["Service d'ophtalmologie, Hopital Pellegrin-CHU de Bordeaux, Bordeaux, France; Universit\u00e9 Bordeaux Segalen, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France","INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France","Service d'ophtalmologie, Hopital Pellegrin\u2014CHU de Bordeaux, Bordeaux, France","Universit\u00e9 Bordeaux Segalen, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'ophtalmologie, Hopital Pellegrin-CHU de Bordeaux, Bordeaux, France; Universit\u00e9 Bordeaux Segalen, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I3018323443","https://openalex.org/I4210112727","https://openalex.org/I4405256745"]},{"raw_affiliation_string":"INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Service d'ophtalmologie, Hopital Pellegrin\u2014CHU de Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]},{"raw_affiliation_string":"Universit\u00e9 Bordeaux Segalen, Bordeaux, France","institution_ids":["https://openalex.org/I4405256745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061673504","display_name":"Robert Vitti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Vitti","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037977466","display_name":"Tummy Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146241","display_name":"Bayer (China)","ror":"https://ror.org/05d5yxq17","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210146241","https://openalex.org/I67348948"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tummy Li","raw_affiliation_strings":["Bayer HealthCare Pharmaceuticals, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare Pharmaceuticals, Beijing, China","institution_ids":["https://openalex.org/I4210146241"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031437634","display_name":"Brigitte Stemper","orcid":"https://orcid.org/0009-0002-0550-8121","observed_orcids":["https://orcid.org/0009-0002-0550-8121"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Brigitte Stemper","raw_affiliation_strings":["Bayer HealthCare Pharmaceuticals, Berlin, Germany; Department of Neurology, University of Erlangen-N\u00fcrnberg, Erlangen, Germany","Bayer HealthCare Pharmaceuticals, Berlin, Germany","Department of Neurology, University of Erlangen-N\u00fcrnberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare Pharmaceuticals, Berlin, Germany; Department of Neurology, University of Erlangen-N\u00fcrnberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]},{"raw_affiliation_string":"Bayer HealthCare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Department of Neurology, University of Erlangen-N\u00fcrnberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020453219","display_name":"Friedrich Asmus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]},{"id":"https://openalex.org/I4210141865","display_name":"Hertie Institute for Clinical Brain Research","ror":"https://ror.org/04zzwzx41","country_code":"DE","type":"other","lineage":["https://openalex.org/I4210094118","https://openalex.org/I4210141865","https://openalex.org/I8087733"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Friedrich Asmus","raw_affiliation_strings":["Bayer HealthCare Pharmaceuticals, Berlin, Germany; Department of Neurodegeneration, Center of Neurology, University Hospital of T\u00fcbingen, and Hertie Institute for Clinical Brain Research, T\u00fcbingen, Germany","Bayer HealthCare Pharmaceuticals, Berlin, Germany","Department of Neurodegeneration, Center of Neurology, University Hospital of T\u00fcbingen, and Hertie Institute for Clinical Brain Research, T\u00fcbingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare Pharmaceuticals, Berlin, Germany; Department of Neurodegeneration, Center of Neurology, University Hospital of T\u00fcbingen, and Hertie Institute for Clinical Brain Research, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210094118","https://openalex.org/I4210141865","https://openalex.org/I8087733"]},{"raw_affiliation_string":"Bayer HealthCare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Department of Neurodegeneration, Center of Neurology, University Hospital of T\u00fcbingen, and Hertie Institute for Clinical Brain Research, T\u00fcbingen, Germany","institution_ids":["https://openalex.org/I4210141865","https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065670758","display_name":"Oliver Zeitz","orcid":"https://orcid.org/0000-0003-4115-7728","observed_orcids":["https://orcid.org/0000-0003-4115-7728"]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Oliver Zeitz","raw_affiliation_strings":["Bayer HealthCare Pharmaceuticals, Berlin, Germany; Klinik und Poliklinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Germany","Bayer HealthCare Pharmaceuticals, Berlin, Germany","Klinik und Poliklinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer HealthCare Pharmaceuticals, Berlin, Germany; Klinik und Poliklinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]},{"raw_affiliation_string":"Bayer HealthCare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Klinik und Poliklinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109832988","display_name":"Tatsuro Ishibashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135598925","display_name":"Kyushu University","ror":"https://ror.org/00p4k0j84","country_code":"JP","type":"education","lineage":["https://openalex.org/I135598925"]},{"id":"https://openalex.org/I4210097767","display_name":"Kyushu University Hospital","ror":"https://ror.org/00ex2fc97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tatsuro Ishibashi","raw_affiliation_strings":["Department of Ophthalmology, Kyushu University, Fukuoka, Japan. Electronic address: ishi@eye.med.kyushu-u.ac.jp","Department of Ophthalmology, Kyushu University, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Kyushu University, Fukuoka, Japan. Electronic address: ishi@eye.med.kyushu-u.ac.jp","institution_ids":["https://openalex.org/I135598925"]},{"raw_affiliation_string":"Department of Ophthalmology, Kyushu University, Fukuoka, Japan","institution_ids":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":20,"corresponding_author_ids":["https://openalex.org/A5109832988"],"corresponding_institution_ids":["https://openalex.org/I135598925","https://openalex.org/I4210097767"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":20.7987,"has_fulltext":false,"cited_by_count":209,"citation_normalized_percentile":{"value":0.9970996,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"122","issue":"6","first_page":"1220","last_page":"1227"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myopic-choroidal-neovascularization","display_name":"myopic choroidal neovascularization","score":0.9649999737739563},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.9940000176429749},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9639999866485596},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/high-myopia","display_name":"high myopia","score":0.8190000057220459},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.9440000057220459},{"id":"https://openalex.org/keywords/retinal-thickness","display_name":"retinal thickness","score":0.7710000276565552},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4650000035762787},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.9912373423576355},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9529757499694824},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6470288634300232},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6089640259742737},{"id":"https://openalex.org/C2781359195","wikidata":"https://www.wikidata.org/wiki/Q5105209","display_name":"Choroidal neovascularization","level":3,"score":0.5735909342765808},{"id":"https://openalex.org/C259533","wikidata":"https://www.wikidata.org/wiki/Q193933","display_name":"Dioptre","level":3,"score":0.49641329050064087},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.4913271963596344},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4595469832420349},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.30975931882858276},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3005552887916565},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1165342628955841}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D041623","descriptor_name":"Tomography, Optical Coherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D047728","descriptor_name":"Myopia, Degenerative","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D047728","descriptor_name":"Myopia, Degenerative","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D047728","descriptor_name":"Myopia, Degenerative","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ophtha.2015.01.025","doi":"https://doi.org/10.1016/j.ophtha.2015.01.025","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ophtha.2015.01.025","pdf_url":null,"source":{"id":"https://openalex.org/S207341048","display_name":"Ophthalmology","issn_l":"0161-6420","issn":["0161-6420","1549-4713"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology","raw_type":"journal-article"},{"id":"pmid:25745875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25745875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7300000190734863,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W110906275","https://openalex.org/W146237123","https://openalex.org/W193657518","https://openalex.org/W233579014","https://openalex.org/W1968189763","https://openalex.org/W1976154023","https://openalex.org/W1979682221","https://openalex.org/W1995046026","https://openalex.org/W2003759790","https://openalex.org/W2004117352","https://openalex.org/W2004361001","https://openalex.org/W2007205785","https://openalex.org/W2028741508","https://openalex.org/W2060609110","https://openalex.org/W2063241000","https://openalex.org/W2065651845","https://openalex.org/W2068651555","https://openalex.org/W2081727392","https://openalex.org/W2102463203","https://openalex.org/W2103269419","https://openalex.org/W2103827117","https://openalex.org/W2121744861","https://openalex.org/W2156799887","https://openalex.org/W2166985747","https://openalex.org/W2172223254","https://openalex.org/W2728697159","https://openalex.org/W2748001554","https://openalex.org/W4240897419"],"related_works":["https://openalex.org/W2274368713","https://openalex.org/W2268276462","https://openalex.org/W4388844555","https://openalex.org/W2039044698","https://openalex.org/W3128198827","https://openalex.org/W4378349177","https://openalex.org/W7216755419","https://openalex.org/W4319225907","https://openalex.org/W2890489468","https://openalex.org/W2064055550"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":28},{"year":2022,"cited_by_count":24},{"year":2021,"cited_by_count":23},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":24},{"year":2018,"cited_by_count":19},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":21},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}